Infliximab for fistulas: a hole in one?
Korzenik
J R
JR
Washington University School of Medicine, St. Louis, Missouri, USA.
D000009:Abdominal Muscles; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D017577:Cutaneous Fistula / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D007412:Intestinal Fistula / Q000188:drug therapy* / Q000209:etiology; D012003:Rectal Fistula / Q000188:drug therapy / Q000209:etiology; D012449:Safety; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab